Medical Biotechnology and Molecular Medicine ((Classe LM-9)-Enrolled from 2016/17 Academic Year
Master programme
A.Y. 2021/2022
LM-9 - Biotecnologie mediche, veterinarie e farmaceutiche (EN)
The Master Programme in Medical Biotechnology and Molecular Medicine is committed to form professionals, provided with a strong technical and theoretical background. The expected evolution of their careers will be to develop scientific methodologies and coordinate research projects in the fields of applied biotechnology and translational medicine. The Master Programme will provide students with a strong educational background on the genetic and molecular bases of diseases and the pathophysiological mechanisms that occur in humans in pathological states, in order to develop diagnostic and therapeutic strategies based on biotechnology. This knowledge will be integrated with a specific formation in the fields of informatics, biophysics, nanotechnology and pharmacology. The Master Programme is organized in common and curricular learning activities focused on neuroscience, oncology, molecular diagnostics and immunobiotechnology. As a part of the common course, the students will learn about economic management of a scientific project, with emphasis on the construction of a business plan and cost analysis. The Master Programme dedicates a long period of time, almost the entire second year, to laboratory activities in which the student, under the supervision of a tutor, will autonomously develop and apply different experimental approaches in the context of a wider research project. This activity will be finalized to the preparation of the degree programme final exam.
The objective of the course is to provide the scientific community with experts in the fields of medical biotechnology and molecular medicine able to develop new experimental models for the study of human diseases, to develop new diagnostic approaches, to identify new therapeutic molecules, to devise innovative drug delivery systems. All these possibilities arise from the competences of the Master's graduate who will have a strong medical educational background that will allow her/him to represent a fruitful interface with the clinics, building a bridge between the bench and the bedside. A deep knowledge of the pathogenetic mechanisms of diseases is required in order to apply basic disciplines to the resolution of medical problems.
Employment opportunities: public and private research structures, including Universities, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health); Hospitals; private pharmaceutical, diagnostics and biotechnological companies; companies supporting scientific research (instruments, biotechnological reagents); companies involved in science communication and publishing.
Below a list of professional profiles:
Medical Science Liaison (MSL) within pharmaceutical and biotechnological companies
In the pharmaceutical and biotechnological companies, this new professional figure has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company.This professional has a strong medical and pharmacological background that enable her/him to talk with physicians in order to solve clinical problem related to the use of specific drugs.
Clinical Monitor within pharmaceutical and biotechnological companies; CRO (Clinical Research Organization) (upon completion of a specific training course)
Thanks to the strong background in pharmacology and statistics this expert will be able to coordinate clinical studies.
Market Access Manager within pharmaceutical and biotechnological companies; consulting agencies, AIFA (Italian agency for drugs) (upon completion of a specific training course)
Thanks to the strong background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs, the graduate will be in the ideal position to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products.
Medical and scientific communication advisor within scientific and medical communication agencies and publishers
Thanks to the multidisciplinary approaches to medical sciences acquired during the course, the Master Programme' graduate may evolve into a medical writer or a consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education or again as an advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
The graduates in the Master Program in Medical Biotechnology and Molecular Medicine will have access to PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
Employment opportunities: public and private research structures, including Universities, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health); Hospitals; private pharmaceutical, diagnostics and biotechnological companies; companies supporting scientific research (instruments, biotechnological reagents); companies involved in science communication and publishing.
Below a list of professional profiles:
Medical Science Liaison (MSL) within pharmaceutical and biotechnological companies
In the pharmaceutical and biotechnological companies, this new professional figure has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company.This professional has a strong medical and pharmacological background that enable her/him to talk with physicians in order to solve clinical problem related to the use of specific drugs.
Clinical Monitor within pharmaceutical and biotechnological companies; CRO (Clinical Research Organization) (upon completion of a specific training course)
Thanks to the strong background in pharmacology and statistics this expert will be able to coordinate clinical studies.
Market Access Manager within pharmaceutical and biotechnological companies; consulting agencies, AIFA (Italian agency for drugs) (upon completion of a specific training course)
Thanks to the strong background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs, the graduate will be in the ideal position to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products.
Medical and scientific communication advisor within scientific and medical communication agencies and publishers
Thanks to the multidisciplinary approaches to medical sciences acquired during the course, the Master Programme' graduate may evolve into a medical writer or a consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education or again as an advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
The graduates in the Master Program in Medical Biotechnology and Molecular Medicine will have access to PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
Italian and European students admitted to attend the Master Program are identified by a graded list determined on the basis of the scores of the admission test. This graded list will be also used for the choice of the curriculum. See below for extra European students*
The date of the entrance test will be communicated later in the announcement of selection published on the website of UNIMI.
For Italian, European or equivalent candidates the selection will be on the basis of a competitive written entrance exam. The admission test consists of a written test based on multiple-choice questions. The admission test will be in English and will include 50 questions on topics such as biology, biochemistry, physics, pharmacology, immunology, pathology, genetics.
*For non-EU students resident abroad (applicants for a student visa) the selection will be based on assessment of the personal and scholastic curriculum.
The date of the entrance test will be communicated later in the announcement of selection published on the website of UNIMI.
For Italian, European or equivalent candidates the selection will be on the basis of a competitive written entrance exam. The admission test consists of a written test based on multiple-choice questions. The admission test will be in English and will include 50 questions on topics such as biology, biochemistry, physics, pharmacology, immunology, pathology, genetics.
*For non-EU students resident abroad (applicants for a student visa) the selection will be based on assessment of the personal and scholastic curriculum.
Transfer requirements
To be admitted to the entrance test, candidates from Italian and EU universities have to possess 180 ects obtained in the Bachelor's degree. Specifically, 50 ects have to derive from the following areas: BIO/09 (Physiology), BIO/10 (Biochemistry), BIO/11 (Molecular biology), BIO/12 (Clinical biochemistry), BIO/13 (Biology), BIO/14 (Pharmacology), BIO/16 (Human anatomy), BIO/18 (Genetics), BIO/19 (General microbiology), MED/01 (Medical statistics), MED/03 (Human genetics), MED/04 (General pathology and immunology), MED/05 (Clinical pathology), MED/06 (Medical oncology), MED/07 (Microbiology), MED/08 (Pathology), MED/09 (Internal medicine), MED/25 (Mental health), MED/26 (Neurology), MED/46 (Laboratory medicine), INF/01 (Informatics), FIS/07 (Medical physics).
For non-EU students resident abroad (applicants for a student visa) the admission to the Master Programme will be based on the assessment of the personal and scholastic curriculum
In order to profitably follow the learning activities, the candidate should have a good knowledge of spoken and written English. The B2 level is required and the certification has to be provided at the registration of the admission test.
Students waiting to obtain the Bachelor's Degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they will obtain the Bachelor degree by December 31th, also possessing the prerequisite described above.
More details about the selection/admission procedure can be find below in the Admission Criteria paragraph.
For non-EU students resident abroad (applicants for a student visa) the admission to the Master Programme will be based on the assessment of the personal and scholastic curriculum
In order to profitably follow the learning activities, the candidate should have a good knowledge of spoken and written English. The B2 level is required and the certification has to be provided at the registration of the admission test.
Students waiting to obtain the Bachelor's Degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they will obtain the Bachelor degree by December 31th, also possessing the prerequisite described above.
More details about the selection/admission procedure can be find below in the Admission Criteria paragraph.
The Master programme in Medical Biotechnology and Molecular Medicine supports international mobility with leading international universities, as well as the possibility for students to earn credits through exchange education and training programmes with Partner organizations.
Available programmes:
- Bilateral agreements in the framework of the Erasmus + programme with: University of Leuven (Katolieke Universiteit Leuven, Belgium), Leids Universitair Medish Centrum (LUMC) of the University of Leiden (Netherland) and University of Cantabria (Universidad de Cantabria, Spain).
- Traineeship with: Institute for Research in Biomedicine (IRB - Bellinzona, Switzerland), Tohoku Medical and Pharmaceutical Univesity (Japan), Tokushima University (Japan).
In recent years, a growing number of students have developed their professionalism and the European dimension of their training through residence periods abroad. Associated universities represent highly recognized European institutions, featuring reference schools (Master and PhD schools) in biomedical sciences and offer the possibility of carrying out research activities in a wide range of scientific fields covered by the Degree Programme. The students will thus be offered exciting opportunities to enhance their CVs and evaluate their interests in extending their careers in the international setting.
The Master course in Medical Biotechnology and Molecular Medicine offers second year students the possibility to carry out the entire practical training for the preparation of their final thesis work in one of the aforementioned institutions or with other institutions with which an agreement has been established. The student will have to define a research project related to his/her course of studies and curricular training, with the joint agreement of both the Unimi and the foreign tutors. The period abroad amounts to 9 months equivalent to 32 credits. A positive evaluation of the period abroad is required. The latter should be defined by the tutor in the foreign university, the Unimi tutor and is subjected to the approval by the Unimi Didactic Council. Erasmus students who obtain outstanding results, proved by an official evaluation letter of the foreign tutor to the President of the Masters Commission, will be rewarded with 1-2 additional points in the final Laurea Grade.
Besides general informative meetings organized by the University, the Degree course in Medical Biotechnology provides specific support to interested/selected students through the organization of specific informative session and/or meeting with the tutor for mobility.
Available programmes:
- Bilateral agreements in the framework of the Erasmus + programme with: University of Leuven (Katolieke Universiteit Leuven, Belgium), Leids Universitair Medish Centrum (LUMC) of the University of Leiden (Netherland) and University of Cantabria (Universidad de Cantabria, Spain).
- Traineeship with: Institute for Research in Biomedicine (IRB - Bellinzona, Switzerland), Tohoku Medical and Pharmaceutical Univesity (Japan), Tokushima University (Japan).
In recent years, a growing number of students have developed their professionalism and the European dimension of their training through residence periods abroad. Associated universities represent highly recognized European institutions, featuring reference schools (Master and PhD schools) in biomedical sciences and offer the possibility of carrying out research activities in a wide range of scientific fields covered by the Degree Programme. The students will thus be offered exciting opportunities to enhance their CVs and evaluate their interests in extending their careers in the international setting.
The Master course in Medical Biotechnology and Molecular Medicine offers second year students the possibility to carry out the entire practical training for the preparation of their final thesis work in one of the aforementioned institutions or with other institutions with which an agreement has been established. The student will have to define a research project related to his/her course of studies and curricular training, with the joint agreement of both the Unimi and the foreign tutors. The period abroad amounts to 9 months equivalent to 32 credits. A positive evaluation of the period abroad is required. The latter should be defined by the tutor in the foreign university, the Unimi tutor and is subjected to the approval by the Unimi Didactic Council. Erasmus students who obtain outstanding results, proved by an official evaluation letter of the foreign tutor to the President of the Masters Commission, will be rewarded with 1-2 additional points in the final Laurea Grade.
Besides general informative meetings organized by the University, the Degree course in Medical Biotechnology provides specific support to interested/selected students through the organization of specific informative session and/or meeting with the tutor for mobility.
The student is required to attend all the teaching activities, with a tolerance of no more than 25% of the hours.
Students are required to sign their attendance at each learning activities. Should the number of absences be higher than 25%, the Teaching Committee will take the necessary measures.
Students are required to sign their attendance at each learning activities. Should the number of absences be higher than 25%, the Teaching Committee will take the necessary measures.
Courses list
course year not available
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | 42 | MED/04 | |
| - Internal medicine | 6 | 42 | MED/09 | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | 69.5 | BIO/13 | |
| - Medical genetics | 6 | 42 | MED/03 | |
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Molecular diagnostics and therapy | 6 | 42 | English | BIO/14 MED/26 MED/36 |
| - Neurology | 2 | 14 | MED/26 | |
| - Pharmacology | 3 | 21 | BIO/14 | |
| - Radiology | 1 | 7 | MED/36 | |
| Neurobiology | 6 | 42 | English | BIO/09 BIO/10 BIO/14 MED/26 |
| - Biochemistry | 1 | 7 | BIO/10 | |
| - Neurology | 1 | 7 | MED/26 | |
| - Pharmacology | 1 | 7 | BIO/14 | |
| - Physiology | 3 | 21 | BIO/09 | |
| Pathogenetic bases of neurological and psychiatric disorders | 6 | 42 | English | BIO/11 MED/13 MED/25 MED/26 |
| - Endocrinology | 1 | 7 | MED/13 | |
| - Mental health | 2 | 14 | MED/25 | |
| - Molecular biology | 1 | 7 | BIO/11 | |
| - Neurology | 2 | 14 | MED/26 | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | 35 | SECS-P/02 | |
| - History of medicine | 6 | 42 | MED/02 | |
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
course year not available
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | 42 | MED/04 | |
| - Internal medicine | 6 | 42 | MED/09 | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | 69.5 | BIO/13 | |
| - Medical genetics | 6 | 42 | MED/03 | |
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer immunology (ONC) | 6 | 42 | English | MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | 14 | MED/15 | |
| - General pathology and immunology | 2 | 14 | MED/04 | |
| - Medical oncology | 2 | 14 | MED/06 | |
| Epidemiology, pathogenesis and diagnostics of cancer | 6 | 42 | English | MED/01 MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | 14 | MED/15 | |
| - General pathology and immunology | 1 | 7 | MED/04 | |
| - Medical Oncology | 2 | 14 | MED/06 | |
| - Medical statistics | 1 | 7 | MED/01 | |
| Research and development of new diagnostic and therapeutic metodologies | 6 | 42 | English | BIO/11 MED/08 MED/15 MED/36 |
| - Blood diseases | 2 | 14 | MED/15 | |
| - Molecular biology | 2 | 14 | BIO/11 | |
| - Pathology | 1 | 7 | MED/08 | |
| - Radiology | 1 | 7 | MED/36 | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | 35 | SECS-P/02 | |
| - History of medicine | 6 | 42 | MED/02 | |
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
course year not available
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | 42 | MED/04 | |
| - Internal medicine | 6 | 42 | MED/09 | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | 69.5 | BIO/13 | |
| - Medical genetics | 6 | 42 | MED/03 | |
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced techniques in medical biotechnology | 6 | 42 | English | BIO/10 BIO/11 BIO/13 MED/40 |
| - Biochemistry | 2 | 14 | BIO/10 | |
| - Biology | 2 | 14 | BIO/13 | |
| - Molecular biology | 1 | 7 | BIO/11 | |
| - Obstetrics and gynecology | 1 | 7 | MED/40 | |
| Data and laboratory management | 6 | 42 | English | MED/01 MED/05 MED/43 MED/46 |
| - Clinical pathology | 2 | 14 | MED/05 | |
| - Forensic medicine | 2 | 14 | MED/43 | |
| - Laboratory medicine | 1 | 7 | MED/46 | |
| - Medical statistics | 1 | 7 | MED/01 | |
| Molecular diagnostics | 6 | 42 | English | BIO/12 MED/03 MED/07 |
| - Clinical biochemistry | 2 | 14 | BIO/12 | |
| - Human genetics | 2 | 14 | MED/03 | |
| - Microbiology | 2 | 14 | MED/07 | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | 35 | SECS-P/02 | |
| - History of medicine | 6 | 42 | MED/02 | |
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
course year not available
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced microscopic techniques and nanotechnology | 6 | 51 | English | FIS/07 |
| Applied pharmacology to biotechnology | 7 | 67 | English | BIO/14 |
| Pathogenetic basis of diseases | 12 | 84 | English | MED/04 MED/09 |
| - General pathology and immunology | 6 | 42 | MED/04 | |
| - Internal medicine | 6 | 42 | MED/09 | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and molecular bases of diseases | 14 | 111.5 | English | BIO/13 MED/03 |
| - Biology | 8 | 69.5 | BIO/13 | |
| - Medical genetics | 6 | 42 | MED/03 | |
| Human biochemistry | 9 | 76.5 | English | BIO/10 |
| Molecular biology applied to biotechnology | 7 | 67 | English | BIO/11 |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer immunology (IMM) | 6 | 42 | English | MED/04 MED/06 MED/15 |
| - Blood diseases | 2 | 14 | MED/15 | |
| - General pathology and immunology | 2 | 14 | MED/04 | |
| - Medical oncology | 2 | 14 | MED/06 | |
| Experimental immunology and immunobiotechnology | 6 | 42 | English | MED/04 MED/16 MED/46 VET/05 |
| - Domestic animal infectious diseases | 2 | 14 | VET/05 | |
| - General pathology and immunology | 1 | 7 | MED/04 | |
| - Laboratory medicine | 2 | 14 | MED/46 | |
| - Reumatology | 1 | 7 | MED/16 | |
| Transplantation and tissue engineering | 6 | 51 | English | ING-IND/34 MED/15 MED/18 MED/43 |
| - Blood diseases | 1 | 7 | MED/15 | |
| - Forensic medicine | 1 | 7 | MED/43 | |
| - General surgery | 3 | 30 | MED/18 | |
| - Industrial bioengineering | 1 | 7 | ING-IND/34 | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing training activities | 4 | 80 | English | |
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further learning activities (linguistic, informatic, relational) | 3 | 45 | English | |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social aspects of biotechnology | 11 | 77 | English | MED/02 SECS-P/02 |
| - Economical politics | 5 | 35 | SECS-P/02 | |
| - History of medicine | 6 | 42 | MED/02 | |
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Degree programme final exam | 21 | 0 | English | |
Study plan rules
- In the first year, the student must gain 4 ects of further electives
- In the second year, the student must gain 4 ects of further electives
In order to start the laboratory activity, the students has to pass 7 exams: the 6 common exams and, afterwards, 1 exam out of his specific curriculum.
Course location
Milano
Presidente del Collegio Didattico
Prof.ssa Maura Francolini
Docenti tutor
Prof. Massimo Locati - Academic guidance tutor
Prof. Diego Fornasari - Internship tutor
Prof.ssa Anna Marozzi - Internship tutor
Dott.sa Federica Compostella - Erasmus and international mobility tutor
Prof. Diego Fornasari - Internship tutor
Prof.ssa Anna Marozzi - Internship tutor
Dott.sa Federica Compostella - Erasmus and international mobility tutor
Reference structures
Contacts
- International Students - Welcome desk:
[email protected] - Student secretary: Mrs Lucia Loseto
Dip. Biotecnologie Mediche e Medicina Traslazionale sede di via Vanvitelli, 32
[email protected]
+390250317123
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
A.Y. 2020/2021
Official documents